Journal article 613 views 301 downloads
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells
Siobhan Crittenden 
,
Marie Goepp ,
Jolinda Pollock ,
Calum T. Robb ,
Danielle J. Smyth ,
You Zhou ,
Robert Andrews ,
Victoria Tyrrell ,
Konstantinos Gkikas ,
Alexander Adima ,
Richard A. O’Connor ,
Luke Davies ,
Xue-Feng Li,
Hatti X. Yao,
Gwo-Tzer Ho,
Xiaozhong Zheng,
Amil Mair,
Sonja Vermeren ,
Bin-Zhi Qian ,
Damian J. Mole ,
Konstantinos Gerasimidis,
Jürgen K. J. Schwarze ,
Richard M. Breyer ,
Mark J. Arends ,
Valerie B. O’Donnell ,
John P. Iredale,
Stephen M. Anderton,
Shuh Narumiya ,
Rick M. Maizels,
Adriano G. Rossi,
Sarah E. Howie ,
Chengcan Yao
,
Marie Goepp ,
Jolinda Pollock ,
Calum T. Robb ,
Danielle J. Smyth ,
You Zhou ,
Robert Andrews ,
Victoria Tyrrell ,
Konstantinos Gkikas ,
Alexander Adima ,
Richard A. O’Connor ,
Luke Davies ,
Xue-Feng Li,
Hatti X. Yao,
Gwo-Tzer Ho,
Xiaozhong Zheng,
Amil Mair,
Sonja Vermeren ,
Bin-Zhi Qian ,
Damian J. Mole ,
Konstantinos Gerasimidis,
Jürgen K. J. Schwarze ,
Richard M. Breyer ,
Mark J. Arends ,
Valerie B. O’Donnell ,
John P. Iredale,
Stephen M. Anderton,
Shuh Narumiya ,
Rick M. Maizels,
Adriano G. Rossi,
Sarah E. Howie ,
Chengcan Yao
Science Advances, Volume: 7, Issue: 7
Swansea University Author:
Luke Davies
-
PDF | Version of Record
Copyright © 2021 The Authors. Distributed under a Creative Commons Attribution License 4.0 (CC BY).
Download (10.05MB)
DOI (Published version): 10.1126/sciadv.abd7954
Abstract
The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells (Tregs), yet how the microbiota-Treg cross-talk is physiologically controlled is incompletely defined. Here, we report that prostaglandin E2 (PGE2)...
| Published in: | Science Advances |
|---|---|
| ISSN: | 2375-2548 |
| Published: |
American Association for the Advancement of Science (AAAS)
2021
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa61695 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| first_indexed |
2022-11-07T14:38:18Z |
|---|---|
| last_indexed |
2023-01-13T19:22:37Z |
| id |
cronfa61695 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-11-07T14:44:14.7056555</datestamp><bib-version>v2</bib-version><id>61695</id><entry>2022-10-31</entry><title>Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells</title><swanseaauthors><author><sid>ff080296775381560053d5e3a6e81745</sid><ORCID>0000-0001-7767-4060</ORCID><firstname>Luke</firstname><surname>Davies</surname><name>Luke Davies</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-10-31</date><deptcode>BMS</deptcode><abstract>The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells (Tregs), yet how the microbiota-Treg cross-talk is physiologically controlled is incompletely defined. Here, we report that prostaglandin E2 (PGE2), a well-known mediator of inflammation, inhibits mucosal Tregs in a manner depending on the gut microbiota. PGE2 through its receptor EP4 diminishes Treg-favorable commensal microbiota. Transfer of the gut microbiota that was modified by PGE2-EP4 signaling modulates mucosal Treg responses and exacerbates intestinal inflammation. Mechanistically, PGE2-modified microbiota regulates intestinal mononuclear phagocytes and type I interferon signaling. Depletion of mononuclear phagocytes or deficiency of type I interferon receptor diminishes PGE2-dependent Treg inhibition. Together, our findings provide emergent evidence that PGE2-mediated disruption of microbiota-Treg communication fosters intestinal inflammation.</abstract><type>Journal Article</type><journal>Science Advances</journal><volume>7</volume><journalNumber>7</journalNumber><paginationStart/><paginationEnd/><publisher>American Association for the Advancement of Science (AAAS)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2375-2548</issnElectronic><keywords/><publishedDay>12</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-02-12</publishedDate><doi>10.1126/sciadv.abd7954</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>Cancer Research UK; MRC UK</funders><projectreference/><lastEdited>2022-11-07T14:44:14.7056555</lastEdited><Created>2022-10-31T12:37:08.3745386</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Siobhan</firstname><surname>Crittenden</surname><orcid>0000-0002-4218-7745</orcid><order>1</order></author><author><firstname>Marie</firstname><surname>Goepp</surname><orcid>0000-0003-1659-5689</orcid><order>2</order></author><author><firstname>Jolinda</firstname><surname>Pollock</surname><orcid>0000-0002-2260-592x</orcid><order>3</order></author><author><firstname>Calum T.</firstname><surname>Robb</surname><orcid>0000-0002-0249-7212</orcid><order>4</order></author><author><firstname>Danielle J.</firstname><surname>Smyth</surname><orcid>0000-0001-6080-2679</orcid><order>5</order></author><author><firstname>You</firstname><surname>Zhou</surname><orcid>0000-0002-1743-1291</orcid><order>6</order></author><author><firstname>Robert</firstname><surname>Andrews</surname><orcid>0000-0002-3491-2361</orcid><order>7</order></author><author><firstname>Victoria</firstname><surname>Tyrrell</surname><orcid>0000-0002-2987-118x</orcid><order>8</order></author><author><firstname>Konstantinos</firstname><surname>Gkikas</surname><orcid>0000-0003-1581-6566</orcid><order>9</order></author><author><firstname>Alexander</firstname><surname>Adima</surname><orcid>0000-0002-6467-4827</orcid><order>10</order></author><author><firstname>Richard A.</firstname><surname>O’Connor</surname><orcid>0000-0001-7100-0233</orcid><order>11</order></author><author><firstname>Luke</firstname><surname>Davies</surname><orcid>0000-0001-7767-4060</orcid><order>12</order></author><author><firstname>Xue-Feng</firstname><surname>Li</surname><order>13</order></author><author><firstname>Hatti X.</firstname><surname>Yao</surname><order>14</order></author><author><firstname>Gwo-Tzer</firstname><surname>Ho</surname><order>15</order></author><author><firstname>Xiaozhong</firstname><surname>Zheng</surname><order>16</order></author><author><firstname>Amil</firstname><surname>Mair</surname><order>17</order></author><author><firstname>Sonja</firstname><surname>Vermeren</surname><orcid>0000-0002-8460-0884</orcid><order>18</order></author><author><firstname>Bin-Zhi</firstname><surname>Qian</surname><orcid>0000-0002-5796-1078</orcid><order>19</order></author><author><firstname>Damian J.</firstname><surname>Mole</surname><orcid>0000-0001-6884-7302</orcid><order>20</order></author><author><firstname>Konstantinos</firstname><surname>Gerasimidis</surname><order>21</order></author><author><firstname>Jürgen K. J.</firstname><surname>Schwarze</surname><orcid>0000-0002-6899-748x</orcid><order>22</order></author><author><firstname>Richard M.</firstname><surname>Breyer</surname><orcid>0000-0001-5828-4403</orcid><order>23</order></author><author><firstname>Mark J.</firstname><surname>Arends</surname><orcid>0000-0002-6826-8770</orcid><order>24</order></author><author><firstname>Valerie B.</firstname><surname>O’Donnell</surname><orcid>0000-0003-4089-8460</orcid><order>25</order></author><author><firstname>John P.</firstname><surname>Iredale</surname><order>26</order></author><author><firstname>Stephen M.</firstname><surname>Anderton</surname><order>27</order></author><author><firstname>Shuh</firstname><surname>Narumiya</surname><orcid>0000-0001-8062-6529</orcid><order>28</order></author><author><firstname>Rick M.</firstname><surname>Maizels</surname><order>29</order></author><author><firstname>Adriano G.</firstname><surname>Rossi</surname><order>30</order></author><author><firstname>Sarah E.</firstname><surname>Howie</surname><orcid>0000-0001-7291-3499</orcid><order>31</order></author><author><firstname>Chengcan</firstname><surname>Yao</surname><orcid>0000-0003-3754-2842</orcid><order>32</order></author></authors><documents><document><filename>61695__25674__f14adfb329984a828902580df0d947fd.pdf</filename><originalFilename>61695_VoR.pdf</originalFilename><uploaded>2022-11-07T14:43:08.0009305</uploaded><type>Output</type><contentLength>10533016</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Copyright © 2021 The Authors. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
| spelling |
2022-11-07T14:44:14.7056555 v2 61695 2022-10-31 Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells ff080296775381560053d5e3a6e81745 0000-0001-7767-4060 Luke Davies Luke Davies true false 2022-10-31 BMS The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells (Tregs), yet how the microbiota-Treg cross-talk is physiologically controlled is incompletely defined. Here, we report that prostaglandin E2 (PGE2), a well-known mediator of inflammation, inhibits mucosal Tregs in a manner depending on the gut microbiota. PGE2 through its receptor EP4 diminishes Treg-favorable commensal microbiota. Transfer of the gut microbiota that was modified by PGE2-EP4 signaling modulates mucosal Treg responses and exacerbates intestinal inflammation. Mechanistically, PGE2-modified microbiota regulates intestinal mononuclear phagocytes and type I interferon signaling. Depletion of mononuclear phagocytes or deficiency of type I interferon receptor diminishes PGE2-dependent Treg inhibition. Together, our findings provide emergent evidence that PGE2-mediated disruption of microbiota-Treg communication fosters intestinal inflammation. Journal Article Science Advances 7 7 American Association for the Advancement of Science (AAAS) 2375-2548 12 2 2021 2021-02-12 10.1126/sciadv.abd7954 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University Cancer Research UK; MRC UK 2022-11-07T14:44:14.7056555 2022-10-31T12:37:08.3745386 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Siobhan Crittenden 0000-0002-4218-7745 1 Marie Goepp 0000-0003-1659-5689 2 Jolinda Pollock 0000-0002-2260-592x 3 Calum T. Robb 0000-0002-0249-7212 4 Danielle J. Smyth 0000-0001-6080-2679 5 You Zhou 0000-0002-1743-1291 6 Robert Andrews 0000-0002-3491-2361 7 Victoria Tyrrell 0000-0002-2987-118x 8 Konstantinos Gkikas 0000-0003-1581-6566 9 Alexander Adima 0000-0002-6467-4827 10 Richard A. O’Connor 0000-0001-7100-0233 11 Luke Davies 0000-0001-7767-4060 12 Xue-Feng Li 13 Hatti X. Yao 14 Gwo-Tzer Ho 15 Xiaozhong Zheng 16 Amil Mair 17 Sonja Vermeren 0000-0002-8460-0884 18 Bin-Zhi Qian 0000-0002-5796-1078 19 Damian J. Mole 0000-0001-6884-7302 20 Konstantinos Gerasimidis 21 Jürgen K. J. Schwarze 0000-0002-6899-748x 22 Richard M. Breyer 0000-0001-5828-4403 23 Mark J. Arends 0000-0002-6826-8770 24 Valerie B. O’Donnell 0000-0003-4089-8460 25 John P. Iredale 26 Stephen M. Anderton 27 Shuh Narumiya 0000-0001-8062-6529 28 Rick M. Maizels 29 Adriano G. Rossi 30 Sarah E. Howie 0000-0001-7291-3499 31 Chengcan Yao 0000-0003-3754-2842 32 61695__25674__f14adfb329984a828902580df0d947fd.pdf 61695_VoR.pdf 2022-11-07T14:43:08.0009305 Output 10533016 application/pdf Version of Record true Copyright © 2021 The Authors. Distributed under a Creative Commons Attribution License 4.0 (CC BY). true eng https://creativecommons.org/licenses/by/4.0/ |
| title |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells |
| spellingShingle |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells Luke Davies |
| title_short |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells |
| title_full |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells |
| title_fullStr |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells |
| title_full_unstemmed |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells |
| title_sort |
Prostaglandin E2 promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells |
| author_id_str_mv |
ff080296775381560053d5e3a6e81745 |
| author_id_fullname_str_mv |
ff080296775381560053d5e3a6e81745_***_Luke Davies |
| author |
Luke Davies |
| author2 |
Siobhan Crittenden Marie Goepp Jolinda Pollock Calum T. Robb Danielle J. Smyth You Zhou Robert Andrews Victoria Tyrrell Konstantinos Gkikas Alexander Adima Richard A. O’Connor Luke Davies Xue-Feng Li Hatti X. Yao Gwo-Tzer Ho Xiaozhong Zheng Amil Mair Sonja Vermeren Bin-Zhi Qian Damian J. Mole Konstantinos Gerasimidis Jürgen K. J. Schwarze Richard M. Breyer Mark J. Arends Valerie B. O’Donnell John P. Iredale Stephen M. Anderton Shuh Narumiya Rick M. Maizels Adriano G. Rossi Sarah E. Howie Chengcan Yao |
| format |
Journal article |
| container_title |
Science Advances |
| container_volume |
7 |
| container_issue |
7 |
| publishDate |
2021 |
| institution |
Swansea University |
| issn |
2375-2548 |
| doi_str_mv |
10.1126/sciadv.abd7954 |
| publisher |
American Association for the Advancement of Science (AAAS) |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
1 |
| active_str |
0 |
| description |
The gut microbiota fundamentally regulates intestinal homeostasis and disease partially through mechanisms that involve modulation of regulatory T cells (Tregs), yet how the microbiota-Treg cross-talk is physiologically controlled is incompletely defined. Here, we report that prostaglandin E2 (PGE2), a well-known mediator of inflammation, inhibits mucosal Tregs in a manner depending on the gut microbiota. PGE2 through its receptor EP4 diminishes Treg-favorable commensal microbiota. Transfer of the gut microbiota that was modified by PGE2-EP4 signaling modulates mucosal Treg responses and exacerbates intestinal inflammation. Mechanistically, PGE2-modified microbiota regulates intestinal mononuclear phagocytes and type I interferon signaling. Depletion of mononuclear phagocytes or deficiency of type I interferon receptor diminishes PGE2-dependent Treg inhibition. Together, our findings provide emergent evidence that PGE2-mediated disruption of microbiota-Treg communication fosters intestinal inflammation. |
| published_date |
2021-02-12T04:20:42Z |
| _version_ |
1763754369389428736 |
| score |
11.013371 |